Ligand id: 6646

Name: tolcapone

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 1
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 100.67
Molecular weight 273.06
XLogP 4.62
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Used in the treatment of Parkinson's disease as an adjunctive therapy.
Mechanism Of Action and Pharmacodynamic Effects
Tolcapone inhibits enzyme activity of catechol-O-methyl transferase (COMT). This enzyme would normally degrade the levodopa (dopamine analogue) given alongside tolcapone. But in the presence of the inhibitor the levodopa can be utilised to replace the dopamine lacking in the brains of Parkinson's patients.
External links